Prostate Cancer in Nigeria: Why West African Genetics Make Early Screening Non-Negotiable:
Prostate cancer starts in the prostate gland, part of the male reproductive system. It usually grows slowly, and many people don’t need treatment right away. But some types can spread quickly and are harder to treat. Early diagnosis improves the chances of long-term survival.
Prostate cancer has quietly become the defining cancer crisis for Nigerian men — not simply “a cancer that affects older men everywhere,” but one that behaves differently at a biological level in men of West African ancestry, arrives earlier, and is diagnosed later.
GLOBOCAN 2022 estimates 18,019 new cases and 11,443 deaths in Nigeria in a single year, making prostate cancer the most frequently diagnosed cancer and the leading cause of cancer death among Nigerian men — about 37.5% of all male cancer diagnoses. Nigeria’s mortality rate (27.9 per 100,000) is among the highest in the world.
Types of prostate cancer
If you’re diagnosed with prostate cancer, it’s most likely an adenocarcinoma. Adenocarcinomas start in the cells of glands that secrete fluid, like your prostate. Rarely, prostate cancer forms from other types of cells.
Less common types of prostate cancers include:
- Small cell carcinomas
- Transitional cell carcinomas
- Neuroendocrine tumors
- Sarcomas
The Scale of the Problem:
Sub-Saharan Africa carries a disproportionate share of global prostate cancer mortality, and Nigeria sits at the sharp end of that trend. Two forces combine to produce this gap: a documented higher baseline genetic risk in men of West African descent, and a screening system that remains opportunistic rather than routine. The first is unchangeable; the second is not.
Symptoms of prostate cancer
Early-stage prostate cancer rarely causes symptoms. But as prostate cancer progresses, you may start to notice changes. Contact your healthcare provider if you have any of these symptoms of prostate cancer:
- Frequent, sometimes urgent, need to pee, especially at night
- Weak urine flow or flow that starts and stops
- Pain or burning when you pee (dysuria)
- Loss of bladder control (urinary incontinence)
- Loss of bowel control (fecal incontinence)
- Painful ejaculation and erectile dysfunction (ED)
- Blood in semen or pee
- Pain in your low back, hip or chest
Prostate cancer causes
Why West African Ancestry Changes the Risk Equation:
The HOXB13 X285K variant:
A rare HOXB13 gene variant found almost exclusively in West Africanancestry men is associated with 2.4 times higher overall prostate cancer risk, and roughly 4.5–4.7 times higher odds of aggressive, advanced-stage disease. Carrier rates are highest in Ghana (0.40%) and Nigeria (0.31%), and the variant is believed to have arisen in West Africa 1,500–4,600 years ago.
BRCA2 and DNA repair pathways:
Pathogenic BRCA2 variants — the same gene linked to hereditary breast cancer — are a recognised driver of early-onset, aggressive prostate cancer in men of African descent.
Prostate cancer causes
Experts aren’t sure what causes cells in your prostate to become cancer cells. As with cancer in general, prostate cancer forms when cells divide faster than usual. While normal cells eventually die, cancer cells don’t. Instead, they multiply and grow into a lump called a tumor. As the cells continue to multiply, parts of the tumor can break off and spread to other parts of your body (metastasize).
Luckily, prostate cancer usually grows slowly. Most tumors are diagnosed before the cancer has spread beyond your prostate. Prostate cancer is highly treatable at this stage.
Why Symptoms Alone Are an Unreliable Warning System:
Early-stage prostate cancer is frequently silent, because tumours often don’t affect urinary function until the disease is already advanced. Symptoms are a lagging indicator, not an early-warning system — which is exactly why biomarker-based screening exists.
What the Guidelines Actually Say:
The American Urological Association and American Cancer Society recommend screening discussions from age 50 for average-risk men, but as early as 40–45 for high-risk men — explicitly including men of African ancestry and those with an affected first-degree relative. The 2024 Lancet Commission on prostate cancer cautions against transplanting Western mass-screening models into low- and middleincome countries, favouring targeted, risk-based case-finding instead. Nigeria’s National Strategic Cancer Control Plan (2023–2027) names prostate cancer a priority, but implementation of routine national screening is still catching up.
Frequently Asked Questions:
1.At what age should Nigerian men start thinking about prostate cancer risk?
Age 50 for average risk; 40–45 for men of African ancestry or with a family history, per AUA/ACS guidance.
2.Is prostate cancer in Nigerian men genetically different?
Yes — ancestry-specific variants like HOXB13 X285K, concentrated in West Africa (including Nigeria), are linked to higher and more aggressive risk.
3.Can prostate cancer be present without symptoms?
Yes. Early-stage disease is often silent, which is why biomarker screening — not symptom-watching — is recommended for high-risk men.
4.Does family history matter more for Nigerian men specifically?
It appears to, given the concentration of ancestry-linked aggressivedisease variants in West African populations.
